Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06805370 · ClinicalTrials.gov registry record · NA
Additional Mailed FIT Kits
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 1,700
- Enrollment target
NCT06805370: Completed NA study, sponsored by University of Southern California.
NCT06805370 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 1,700 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (21% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06805370, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,700 participants
- Enrollment target
Study Summary
This study aims to assess whether sending patients in a county health care system additional FIT Kits can increase the FIT Kit return rate enough to warrant the extra cost. To do this, the health system mailed a random subset of patients ages 60 to 75 a FIT Kit in November 2024 in addition to sending patients an annual FIT Kit mailing. This work analyzes the return rate of mailed FIT Kits within 60-days of the November mailing.
Primary Outcome
Indicator of whether a patient successfully returned a FIT Kit to the health system for processing
Interventions
- OTHER Usual Care
- BEHAVIORAL Mailed Additional FIT Kit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,700 participants |
| Start Date | 2024-11-01 |
| Est. Completion | 2025-03-31 |
| Phase | NA |
What the finished NCT06805370 record still lists
NCT06805370 is an interventional study that assigns participants to a tested intervention. Its 1,700 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (21% higher).
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT06805370 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06805370 about?
NCT06805370 is a clinical study titled "Additional Mailed FIT Kits". This study aims to assess whether sending patients in a county health care system additional FIT Kits can increase the FIT Kit return rate enough to warrant the extra cost. To do this, the health system mailed a random subset of patients ages 60 to 75 a FIT Kit in November 2024 in addition to sendin...
What is the current status of trial NCT06805370?
This trial is currently completed. It is a NA study. The enrollment target is 1,700 participants. The study started on 2024-11-01. Estimated completion is 2025-03-31.
What interventions are being tested in trial NCT06805370?
The interventions under investigation include: Usual Care (OTHER), Mailed Additional FIT Kit (BEHAVIORAL).
Who is sponsoring clinical trial NCT06805370?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06805370's enrollment target sits among peer trials
1,700 62nd of 2000 higher than 1,939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04321200 · 1,700 participants
PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
- NCT06238622 · 1,700 participants · Phase 3
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
- NCT07284901 · 1,700 participants · Phase 3
Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- NCT07304531 · 1,705 participants
First To Know Pregnancy Test - Clinical Evaluation Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI